APA (7th ed.) Citation

Zou, L., Rao, X., & Zhao, X. (2025). Clinical features, diagnosis, and treatment of pembrolizumab induced autoimmune encephalitis. Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, 43(2), 191-198. https://doi.org/10.1007/s10637-025-01511-0

Chicago Style (17th ed.) Citation

Zou, Li, Xianlin Rao, and Xiyue Zhao. "Clinical Features, Diagnosis, and Treatment of Pembrolizumab Induced Autoimmune Encephalitis." Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies 43, no. 2 (2025): 191-198. https://doi.org/10.1007/s10637-025-01511-0.

MLA (9th ed.) Citation

Zou, Li, et al. "Clinical Features, Diagnosis, and Treatment of Pembrolizumab Induced Autoimmune Encephalitis." Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, vol. 43, no. 2, 2025, pp. 191-198, https://doi.org/10.1007/s10637-025-01511-0.